Parp Inhibitors - A Cancer Drug Discovery Story | Professor Ruth Plummer Fmedsci

PARP inhibitors – a cancer drug discovery story | Professor Ruth Plummer FMedSci

Newcastle Discover: The Journey of a Cancer Treatment with Professor Ruth Plummer

Newcastle University Alumni

How PARP inhibitors (PARPi) work

ESMO 2010: PARP inhibitors

Understanding the Side Effects of PARP Inhibitors

DNA repair inhibitors to overcome drug resistance

Development and clinical indications of PARP inhibitors

Expert Weighs In On The Future of PARP Inhibitors

Dr. Hardesty on Bevacizumab/PARP Inhibitor Combination in Ovarian Cancer

Dr. Ledermann on Response to Rucaparib in Recurrent Ovarian Cancer

PARP Inhibitors and Indications in Ovarian Cancer

Personalizing Advanced Ovarian Cancer Treatment With PARP Inhibitors and Novel Approaches

PeerView Oncology

PARP Inhibitors: Deciding Among the Available Agents

Dr. Berek Discusses the Impact of PARP Inhibitors on Ovarian Cancer

PARP inhibitors and immunotherapy - Dr Yvette Drew

Target Ovarian Cancer

Dr. Moore on Unanswered Questions With PARP Inhibitors in Ovarian Cancer

Ask an Expert: How Do PARP Inhibitors Work?

Dr. Konecny on Response to PARP Inhibitors in Ovarian Cancer

Matching treatment to molecular profiles in endometrial cancer